Last update:

HIV & AIDS news

US approves cheap generic of breakthrough HIV shot for poorer countries

The U.S. Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries.

Safer solutions: The urgent connection between smoking and HIV

People with HIV now lose more years of life to smoking than to HIV itself. About 1.2 million Americans are living with HIV, and while smoking among U.S. adults has fallen below 10% for the first time, people with HIV still ...

Using AI in the global fight against HIV

When faced with the possibility of an HIV diagnosis, sometimes the best initial prescription is support from a trusted friend—someone who might offer not just emotional guidance but also critical, practical health resources. ...

Has Taylor Swift defanged the toxic term 'Patient Zero' ?

On Sept. 22, Taylor Swift made an unexpected announcement that she was releasing a new single called "Patient Zero." The news sent Swifties and music sleuths on a wild goose chase for online clues to the meaning of the song ...

How a new long-acting HIV drug combo tackles resistance

A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is resistant to some commonly used HIV drugs, according to a new UC San Francisco study.

How a specific protein may drive brain damage in neuroHIV

While powerful medications can suppress the spread of HIV and its progression to AIDS, there are no cures, and many people living with HIV experience nervous system problems. Called neuroHIV, these complications occur when ...

Teaching the immune system to control HIV

There is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must take daily antiretroviral medication for the rest of their lives. Results from a clinical trial ...

Fiji declares national HIV crisis

Fiji has declared a national HIV crisis as sexual transmission and illicit drug use help spread the virus, now infecting an estimated one in 60 adults in the Pacific nation.

What are we dying from?

Cardiovascular diseases now account for a third of deaths in adults over 40 in a rural South African population.

How HIV uses T cells to hide in the gut

Antiretroviral treatments for HIV (human immunodeficiency virus) have been extremely successful in extending life expectancy and reducing transmission. But one major challenge has so far prevented researchers from developing ...

Comorbidities in HIV: Big data study reveals molecular links

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine (CiiM) investigated this ...

Setback in the fight against pediatric HIV

For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where the rate of infection exceeded 30% in some areas of the country in the 1990s.

Early challenges to the immune system disrupt oral health

Modupe O. Coker from the School of Dental Medicine and a collaborative team of researchers identified changes over time in the oral microbiome of children living with HIV, offering insights into how early immune challenges ...

RFK Jr. may remove top panel on preventive services task force

U.S. Health Secretary Robert F. Kennedy Jr. is considering removing all 16 members of an advisory group that helps decide which preventive services, like cancer screenings and HIV medications, should be fully covered by insurance.

Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.